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Case report
  A 53-year- old Malay male presented to the Emergency 
Department (ED) with a complain of enlarging right upper 
chest wall swelling for 4 days. Two days ago, he developed 
persistent high grade fever, chills and rigors. The fever 
partially subsided with paracetamol. No cough, shortness of 
breath, abdominal pain, muscular pain or urinary symptoms 
were presented. the patient suffered from diabetes mellitus 
for the past 15 years, and it was well controlled with 
medication. During the illness he also had frequency in 
micturition, polyuria and nocturia.
  On general physical examination, he appeared lethargic, 
uncomfortable and dehydrated. His oral temperature, pulse 
rate, respiratory rate and blood pressure was 38.5 曟 , 
110 beats per minute, 20 per minute and 125/80 mmHg 
respectively. 
  Precordial examination revealed a huge immobile and 
fluctuant mass over the right upper chest wall measuring 
8 cm 伊 10 cm. The mass was firm, tender and warm with 
ill defined margin (Figure 1), the overlying skin was 
erythematous. Supraclavicular, infraclavicular and axillary 
lymph nodes were not palpable. Lung and abdominal 
examinations were normal. The patient was in sepsis 
secondary to anterior chest wall abscess. Stat dose of 2 g 
cloxacillin was given intravenously because in our opinion 
the most likely organism at that time was Staphylococcus 
aureus. Intravenous normal saline and  insulin infusion was 
also commenced. 
  Laboratory results revealed elevated total white count 
(19.3伊106 /L), hemoglobin and platelet counts were normal. 
Blood urea and serum electrolytes were normal. Erythrocyte 
sedimentation rate and  random blood sugar was raised 
to 119 mm/hour and 25.2 mmol/L respectively. Chest 
radiograph showed soft tissue swelling, normal cardiac 
borders and clear lung fields. Samples for blood culture 
and sensitivity test was sent. Ultrasonography of abdomen 
revealed normal liver and spleen.
  Incision and drainage was done under general anesthesia 
on the next day of admission. A large amount of pus was 
drained and the collected pus was sent for gram stain and 
culture and sensitivity tests. After necrotic tissue removal 
and wound dressing, the wound  was packed with povidone 
soaked gauze. His insulin infusion and antibiotic was 
continued. Gram stain result was not traced till all the 
microbiology results were sent back 3 days later. Gram 
stain of pus showed gram-negative, intracellular, safety 
pin-like bacilli and later blood and pus culture revealed 
growth of Burkholderia psuedomallei. The organism was 
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sensitive to ceftazidime, choramphenicol, ciprofloxacin, 
cefepime, amoxicillin-clavulanate, co-trimoxazole; and 
resistant to amikacin, , gentamicin and netilmicin. 
  Two gram of intravenous ceftazidime was administered 
immediately and followed by 2 g every 8 hours.  He was 
on intravenous ceftazidime and had daily wound dressing 
with normal saline for 6 weeks. He was then continued with 
100 mg oral doxycycline every 12 hour and 480 mg oral 
co-trimoxazole every 12 hour for 20 weeks. His condition 
progressed very well and later secondary suturing was 
done. He was counselled regarding the risk of relapse and 
the eradication therapy, and the importance of the life long 
follow up. During his one year follow up recently, he was 
found to be well with no relapse.
Figure 1. The above picture showing “hot abscess” over the right 
upper chest.
Discussion
  Most of the pyogenic infections are due to aerobic bacteria 
such as Staphylococcus aureus, Streptococcus pyogenes, 
Streptococcus pneumoniae, Neisseria gonorrhoeae, N. 
meningitidis, Bacillus coli communis, Bacillus typhosus 
and others[1]. Staphylococcus aureus is the most common 
organism cultured in soft tissue infections[2] hence, starting 
intravenous cloxacillin empirically for this patient is 
justified. 
  To determine the exact organism based solely on clinical 
presentation poses a great challenge to the physician. 
Empirical antibiotic therapy is not an ideal solution. We 
may miss the responsible organism, killing normal flora 
and it may develop antibiotic resistance. In addition, the 
organism may not be sensitive to the particular antibiotic. 
The patient had a “hot abscess” over his anterior chest wall 
that mimics Staphylococcus aureus infection and sepsis. 
Presence of Burkholderia psuedomallei on blood and pus 
cultures is consistent with septic melioidosis. Delayed 
identification of this organism may result in fatal outcome. 
  Burkhholderia psedomallei is a soil saphropyte readily 
recovered from wet soils in rice fields in endemic areas[3]. 
It is a motile, aerobic, oxidase positive and gram-negative 
bacillus. Gram stain shows the characteristic bipolar 
staining gram-negative rods or “safety pin appearance”[4,5]. 
The organism is introduced to the human body by contact of 
skin lesions with soil or water containing the organism or by 
inhalation and ingestion of infected dust or water particles. 
Uncommon routes of transmission include hematogenous 
spread, nosocomial or laboratory transmission, vertical 
transmission at childbirth and sexual transmission[4-11] .
  Melioidosis is endemic in tropical countries in Southeast 
Asia (Malaysia, Thailand, and Singapore) and Northern 
Australia. The average annual incidence of melioidosis 
in Malaysia (State of Pahang), Singapore, Northeastern 
Thailand and Northern Territory of Australia was 6.0, 1.7, 
4.4 and 16.5 per 100,000 populations respectively[12-15].
  The clinical manifestations of melioidosis range from the 
totally asymptomatic patient to the patient presenting to 
the ED in septic shock[16-18]. Other presentations include 
pneumonia, lung abscess, lung massess and empyema 
chronic otitis media, mycotic aneurysms, brain-stem 
encephalitis and flaccid paraparesis [12,19-21]. Localized 
melioidosis usually occurs in the form of acute suppurative 
lesions or superficial and deep-seated abscess[16]. 
  Chest wall melioidosis is a rare presentation, though 
the disease can manifest over any part of the human 
body. It is important for the physician to consider this 
disease as one of the differential diagnosis of anterior 
chest wall abscess, especially in those who live in an 
endemic area of melioidosis, in Asian migrants, or in 
those with a history of travel to the endemic regions[17]. 
Presence of risk factors such as diabetes mellitus, renal 
failure, cirrhosis, thalassemia, chronic lung disease, 
hematological malignancies, collagen vascular disease and 
immunodeficient by drugs (steroids) makes the diagnosis 
more likely [3]. Patient with poorly controlled diabetes 
mellitus has higher risk to suffer from melioidosis[18]. 
  Melioidosis is a significant cause of morbidity and 
mortality. The morbidity and mortality are related to 
community acquired septicemia and community acquired 
pneumonia. Epidemiology study on melioidosis in 
northeast Thailand revealed the incidence of community 
acquired septicemia and pneumonia to be 27% and 36% 
respectively[15]. In Malaysia the reported mortality rate is up 
to 53.5%.  Majority of them succumbed to the illness due 
to severe pneumonia and multi-organ failure and they died 
within 72 hours of hospital admission[13,19]. The reported 
mortality rate in Northern Australia, Thailand and Singapore 
is 19%, 44% and 46% respectively[12,15,20]. In endemic areas 
of melioidosis like Northern Thailand, whereby majorities 
are seropositive, the mortality rate was noted higher in the 
septicemic group (36.3%) than the non-septicemic group 
(16.5%)[15].
  Early diagnosis of melioidosis leads to early appropriate 
and sensitive antibiotic administration. Isolation and 
identification of the organism from various clinical 
specimens along with its sensitivity to various types of 
antibiotics is vital to confirm the presence of bacterium 
and to eradicate them completely. Since the culture and 
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sensitivity results may only be available after 3 to 7 days, 
immunologic (Indirect hemagglutination and enzyme linked 
immunosorbent assay) and molecular (Polymerase chain 
reaction) tests are now available to diagnose and exclude 
melioidosis rapidly. Unfortunately, its low specificity makes 
the tests unsuitable in endemic areas where most of the 
population is seropositive[15,21].
  The main objective of melioidosis treatment is to reduce 
mortality and morbidity and to prevent relapse. Therefore, 
the mainstay of treatment for this patient is operative 
drainage and intravenous antibiotics, i.e. intensive and 
eradication therapy. Even if the proper antibiotics are given, 
the clinical improvement is usually slow. The median time 
for the resolution of fever is nine days but patients with large 
abscess may have fluctuating fevers for more than 1 month. 
Enlargement of abscesses or appearance of new abscesses 
is not uncommon in the first week of treatment and is not 
necessarily a sign of treatment failure[3]. 
  Relapse can occur in melioidosis. A long course of oral 
eradication therapy is required to prevent relapse[12,22]. The 
treatment may be continued over 12-20 weeks or longer if 
clinically indicated. In our case, the patient received only 
a single intravenous antibiotic (ceftazidime) for 6 weeks 
because we believed an addition of co-trimoxazole during 
the intensive course of antibiotic therapy does not confer 
any additional benefit in mortality[23]. Combination of oral 
doxycycline and co-trimoxazole is a common eradication 
antibiotic in our practice.
  In conclusion, though chest wall melioidosis is very 
rare, a high index of suspicion is needed particularly in 
patients who live in the endemic areas, or patients with 
predisposing factors, as diagnosis can only be established 
by bacteriological and immunological studies. Melioidosis 
has been known to be ‘the great mimicker’ and posed great 
challenge to the physician to identify the correct organism 
clinically. 
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